Disclosures: Raghav Bassi: Nothing to Disclose, Zubair Bodla: Nothing to Disclose, Mariam Hashmi: Nothing to Disclose, Fatima Niaz: Nothing to Disclose, Muhammad Khalil: Nothing to Disclose, Yaseen Perbtani: Nothing to Disclose, Tony Brar: Nothing to Disclose 1676 ACTIVITY METRICS MEASURED BY WEARABLE TECHNOLOGY CORRELATES WITH PATIENT-REPORTED WELLBEING IN CIRRHOSIS Brian McSteen 1 Jessica Siguencia 1 Russell Rosenblatt 2 Arun Jesudian 2 Ana Krieger 2 Avesh Thuluvath 3 Robert Schwartz 4 Robert Brown 2 Adam Buckholz 5 , 1 NewYork-Presbyterian, Weill Cornell Campus, 2 Weill Cornell Medicine, 3 Northwestern University Feinberg School of Medicine, 4 Weill Cornell Medical College, 5 New York Presbyterian Hospital Program Background: Inactivity is associated with progressive sarcopenia, worse transplant outcomes and increased mortality in cirrhosis
GLP-1s are injectable medications that work by increasing insulin production and delaying digestion to control hunger
By keeping track, youll start to notice patterns like nausea after injections, certain foods that trigger symptoms, or times when your protein intake dips
While these medications can work **exceptionally** well, its normal to have some side effects
Proc Natl Acad Sci USA 89(18):86418645 Triplitt C, DeFronzo RA (2006) Exenatide: first-in-class incretin mimetic for the treatment of type 2 diabetes mellitus
Alicia Lydecker, an emergency physician at Albany Medical Center, said that its important to keep researching kratom because the substance might be able to provide pain relief in a safer way than prescription opioids
